- Home
- POLA vs VRAX Comparison
POLA vs VRAX Comparison
Compare POLA & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- VRAX
- Stock Information
- Founded
- POLA 1979
- VRAX 2013
- Country
- POLA United States
- VRAX United Kingdom
- Employees
- POLA N/A
- VRAX N/A
- Industry
- POLA Industrial Machinery/Components
- VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- POLA Miscellaneous
- VRAX Health Care
- Exchange
- POLA Nasdaq
- VRAX Nasdaq
- Market Cap
- POLA 4.3M
- VRAX 4.7M
- IPO Year
- POLA 2016
- VRAX 2022
- Fundamental
- Price
- POLA $1.91
- VRAX $0.91
- Analyst Decision
- POLA
- VRAX Strong Buy
- Analyst Count
- POLA 0
- VRAX 1
- Target Price
- POLA N/A
- VRAX $3.00
- AVG Volume (30 Days)
- POLA 280.1K
- VRAX 55.7K
- Earning Date
- POLA 08-13-2025
- VRAX 02-05-2025
- Dividend Yield
- POLA N/A
- VRAX N/A
- EPS Growth
- POLA N/A
- VRAX N/A
- EPS
- POLA N/A
- VRAX N/A
- Revenue
- POLA $13,918,000.00
- VRAX $6,331.00
- Revenue This Year
- POLA N/A
- VRAX $217,274.83
- Revenue Next Year
- POLA N/A
- VRAX N/A
- P/E Ratio
- POLA N/A
- VRAX N/A
- Revenue Growth
- POLA 8.08
- VRAX N/A
- 52 Week Low
- POLA $1.53
- VRAX $0.74
- 52 Week High
- POLA $4.69
- VRAX $9.00
- Technical
- Relative Strength Index (RSI)
- POLA 62.97
- VRAX 50.78
- Support Level
- POLA $1.82
- VRAX $0.84
- Resistance Level
- POLA $1.97
- VRAX $0.99
- Average True Range (ATR)
- POLA 0.16
- VRAX 0.07
- MACD
- POLA 0.03
- VRAX 0.02
- Stochastic Oscillator
- POLA 33.70
- VRAX 60.20
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.